We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!


Managing FDA After a Bad Inspection

Managing FDA After a Bad Inspection

Overview: The webinar explains how the FDA conducts an inspection and collects evidence to show you failed to meet one or more regulatory requirement. How you respond to the inspection makes a big difference in the FDA's follow up with you. The agency follows well establish procedures for how it evaluates an inspection and uses a number of factors to determine what action it might take after a bad inspection.. If you understand what the FDA does with your inspection results, you may be able to mitigate the financial and marketing damage. You should understand what your competitors may do after your inspection. They can market your bad decision as soon as the inspection is done.Why should you attend: You can prepare a strategy to manage the FDA when you have had a bad inspection. You can even use relevant criteria to determine what the FDA might do after you bad inspection. A failure to act on your part digs you into a deeper regulatory pit. The FDA uses a number of criteria when it evaluates a firm's bad inspection, or as the FDA would say, a "violative inspection." At the end of your inspection, you may ask the investigator, "How bad is it?" You will not get an answer. If you understand how the FDA evaluates inspections, you are ahead of the process. If you do not know what you are doing or try to wing it, you will eventually realize that you should have had a strategy already in place before the inspection even started. After a bad inspection, the FDA will hover over you and you cannot afford naïve, short sighted or misguided mistakes. What strategy do you have? What will you say to the FDA after a bad inspection and how can you get yourself off of the FDA's radarscope? If you follow pay attention to specific issues, you can begin to manage the FDA's follow up. Areas Covered in the Session:FDA's inspection strategyThe evidence against youInspectional List of Observations (Form FDA 483)Discussions with the FDA (To promise not to promise, that is the question.)Responding to the 48Responding to a Warning LetterFDA verification of corrective action


19 May 2015 @ 10:00 am

19 May 2015 @ 11:00 am

Duration: 1 hours

Timezone: GMT -8:00


Online Webinar



Organised by

NetZealous (deactivated)

Premium Events in Trade

Other Events in Trade

Similar Webinars in Trade

2021 EBN Congress

Webinar, 14 Sep 2021

Recent Publications in Trade

Recent Videos in Trade

Space Debris

Trade, 13 Apr 2021

Recent Speakers in Trade

Brian Riise
Director of R&D


David Rosa
business angel


Scott Gearity
ECTI INstructor


Sponsors in Trade

Recent News in Trade

The BBI JU-funded @FARMYNG_EU #flagship #biorefinery 🌱 in @AmiensMetropole, @hautsdefrance 🇫🇷, will create new… https://t.co/m3D6gPwrrd

@EU_Growth - 15 Apr 2021 09:37

🇪🇺 We're happy to announce that Ms Maria Martin-Prat has been appointed as a new Deputy Director-General at DG Trad… https://t.co/2o83MaE51M

@Trade_EU - 14 Apr 2021 17:46

Looking forward to the discussion and talking about creating more and better trade and investment opportunities for… https://t.co/lDafF1MXuN

@Trade_EU - 14 Apr 2021 14:58

Premium EventsLearn more ..